-
Signature
-
YuFan Stephanie Wang, Attorney-in-Fact
-
Issuer symbol
-
PRGS
-
Transactions as of
-
31 Jul 2023
-
Net transactions value
-
-$38,917
-
Form type
-
4
-
Filing time
-
02 Aug 2023, 17:43:55 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PRGS |
Common Stock |
Options Exercise |
$50,037 |
+1,061 |
+20% |
$47.16 |
6,399 |
31 Jul 2023 |
Direct |
F1 |
| transaction |
PRGS |
Common Stock |
Sale |
$63,660 |
-1,061 |
-17% |
$60.00 |
5,338 |
31 Jul 2023 |
Direct |
F2 |
| transaction |
PRGS |
Common Stock |
Options Exercise |
$63,361 |
+1,487 |
+28% |
$42.61 |
6,825 |
01 Aug 2023 |
Direct |
|
| transaction |
PRGS |
Common Stock |
Sale |
$88,655 |
-1,487 |
-22% |
$59.62 |
5,338 |
01 Aug 2023 |
Direct |
F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
PRGS |
Employee Stock Options |
Options Exercise |
$0 |
-1,061 |
-17% |
$0.000000 |
5,300 |
31 Jul 2023 |
Common Stock |
1,061 |
$47.16 |
Direct |
F3 |
| transaction |
PRGS |
Employee Stock Options |
Options Exercise |
$0 |
-1,487 |
-13% |
$0.000000 |
10,405 |
01 Aug 2023 |
Common Stock |
1,487 |
$42.61 |
Direct |
F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: